Clients | Pioneering & Emerging Technologies

Clients spearhead pioneering organizations and emerging technologies seeking to carve new paths in uncharted territory (internally or externally). Presented with an exciting yet overwhelming wide range of future portfolio/partnership possibilities, teams’ early decisions are often real-time, exploratory, and opportunistic.

In building critical mass to the next level, leadership seeks to optimize resources and harvest SME insights to streamline strategies in portfolio/pipeline strategy and corporate business development (strategic partnerships, investments, or divestitures).

Objectives range from mobilizing strategy & execution across partnerships, portfolios/ pipelines, optimizing runways, to building enterprise ecosystems for long-term growth.

F&W | Creating Structure in Whitespace

F&W specializes in strategy and execution for growth through strategic partnership ecosystems with comprehensive corporate development expertise (buy/sell side) across the value chain, from high-level enterprise strategy, portfolio/pipeline planning, search & evaluation/scouting, through to due diligence, transactions, and alliance management.

With emphasis on pioneering and emerging technologies at the intersection of Pharmaceuticals/Biopharma and Medtech/TechBio/Device verticals, F&W brings a comprehensive life science perspective to optimize multimodal programs and collaborations where upside synergies, risks, and program momentum can often get lost in translation.

F&W empowers clients by streamlining workstreams to align multidisciplinary teams and developing actionable risk-managed strategies to execute for growth - bringing extensive expertise leading pioneering cross-sector multinational collaborations and initiatives for budding'start-up’ teams:

• First non-invasive drug delivery for biologics programs (Device & Pharma: J&J/Alza)

• First Molecular Imaging/RLT/Radiation Treatment Planning SaMD programs (Nuclear Medicine, SaMD & Radiopharmaceutical/Theranostics: Philips Medical Systems)

• First Complementary diagnostic Global Health consortium for Malaria (Pharma & POC Diagnostics: GSK/PATH/Bill&Melinda Gates Foundation/DfID)

• First NGS panel companion diagnostic development in Immuno-oncology (Pharma & Medtech: ThermoFisher Scientific/Multinational Pharmas)

Leveraging both strategic leadership & industry frontline operational know-how, F&W connects relevant dots in the big picture (e.g., enterprise strategies/value propositions, market segments, targets/networks, etc) & in the weeds (e.g., contract language, IP, market research/intelligence, process/teams)

F&W brings a mission and data-driven approach to Corporate Development & Strategy - in collaboration across Commercial/Marketing, R&D, Regulatory, Clinical Operations, Finance, Investor Relations, and Legal Domains (IP, contractual) - enabling clients to harness interdisciplinary subject matter expertise for optimal impact toward step-change value creation.

Learn More